JPMorgan Chase & Co. Grows Stake in Lexeo Therapeutics, Inc. (NASDAQ:LXEO)
JPMorgan Chase & Co. increased its holdings in Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) by 30.1% during the fourth quarter, Holdings Channel reports. The firm owned 13,371 shares of the company’s stock after acquiring an additional 3,093 shares during the quarter. JPMorgan Chase & Co.’s holdings in Lexeo Therapeutics were worth $88,000 at the […]
JPMorgan Chase & Co. increased its holdings in Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) by 30.1% during the fourth quarter, Holdings Channel reports. The firm owned 13,371 shares of the company’s stock after acquiring an additional 3,093 shares during the quarter. JPMorgan Chase & Co.’s holdings in Lexeo Therapeutics were worth $88,000 at the […]
